TY - JOUR
T1 - Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma
AU - Agbay, Rose Lou Marie C.
AU - Jain, Nitin
AU - Loghavi, Sanam
AU - Medeiros, L. Jeffrey
AU - Khoury, Joseph D.
N1 - Publisher Copyright:
© 2016 Wiley Periodicals, Inc.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Although generally considered a clinically indolent neoplasm, CLL/SLL may undergo transformation to a clinically aggressive lymphoma. The most common form of transformation, to DLBCL, is also known as Richter syndrome. Transformation determines the course of the disease and is associated with unfavorable patient outcome. Precise detection of transformation and identification of predictive biomarkers and specific molecular pathways implicated in the pathobiology of transformation in CLL/SLL will enable personalized therapeutic approach and provide potential avenues for improving the clinical outcome of patients. In this review, we present an overview of the pathologic features, risk factors, and pathogenic mechanisms of CLL/SLL transformation. Am. J. Hematol. 91:1036–1043, 2016.
AB - Although generally considered a clinically indolent neoplasm, CLL/SLL may undergo transformation to a clinically aggressive lymphoma. The most common form of transformation, to DLBCL, is also known as Richter syndrome. Transformation determines the course of the disease and is associated with unfavorable patient outcome. Precise detection of transformation and identification of predictive biomarkers and specific molecular pathways implicated in the pathobiology of transformation in CLL/SLL will enable personalized therapeutic approach and provide potential avenues for improving the clinical outcome of patients. In this review, we present an overview of the pathologic features, risk factors, and pathogenic mechanisms of CLL/SLL transformation. Am. J. Hematol. 91:1036–1043, 2016.
UR - http://www.scopus.com/inward/record.url?scp=84990192461&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84990192461&partnerID=8YFLogxK
U2 - 10.1002/ajh.24473
DO - 10.1002/ajh.24473
M3 - Review article
C2 - 27414262
AN - SCOPUS:84990192461
SN - 0361-8609
VL - 91
SP - 1036
EP - 1043
JO - American journal of hematology
JF - American journal of hematology
IS - 10
ER -